Triple-negative BC (TNBC) tends to utilize exogenous fatty acids, whereas luminal subtypes appear to depend on a balance between oxidation and de novo fatty acid synthesis as energy sources, and human epidermal growth factor receptor 2-positive (HER2+) BC displays upregulated lipid biosynthesis (10–12). The gene discussed is ERBB2; the disease is breast cancer.